Disorders related to circadian rhythms can majorly be classified as extrinsic type and intrinsic type. Extrinsic type involves the sleep disorders affected by external factors such as working shifts-night shifts and rotational shifts. The constant or recurrent pattern of sleep interruption resulting in insomnia or excessive sleepiness is the symptom of shift work disorder. Intrinsic type of sleep disorder is the inbuilt disorder in someone's body. These include Advanced Sleep Phase Disorder (ASPD), Delayed Sleep Phase Disorder (DSPD), Irregular sleep?wake rhythm, and Non-24-hour sleep?wake disorder. Owing to the impact of western culture, modernization, and industrialization these disorders are commonly seen in people working in corporate environment. Hence the demand for its diagnosis, therapies, and treatment has increased for past 5 years which is expected to surge at high rate in near future. The report gives detailed analysis and market estimation of these disorders, their diagnosis and treatments.
Circadian Rhythm Sleep Disorder Market
The report gives detailed insights on the market dynamics such as drivers, inhibitors, and opportunities in this market. The major industry trends demand and supply side factors, micro and macro factors affecting the market and industry attractiveness are analyzed and infographically presented in the report.
The report gives region and country-wise analysis of market dynamics and trends of circadian rhythm sleep disorder market. The major geographies covered in the report are North America, Europe, Asia-Pacific, Middle-East, & Africa, and Latin America. Likewise, country level analysis of all the major regions is also covered in the report.
The report also covers market entropy study of competitiveness in the market. The special focus is given on the business developments strategies adopted by the major players in the market. The impact of new product launches, mergers & acquisitions, collaborations, partnerships, and JVs on the market is analyzed in the report. The competitiveness of the market is analyzed based on the profiling of the key pharmaceutical players in the market.
The key players profiled in the report include:
Vanda Pharmaceuticals, Inc
Takeda Pharmaceutical Company Limited
VU University Medical Center
U.S. Centers of Disease Control and Prevention
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Circadian Rhythm Sleep Disorder Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. End-User Profiling
3.2.2. Patent Analysis
3.2.3. Financial Analysis of Top 5 Players
4. Circadian Rhythm Sleep Disorder Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of Industry
4.4.1. Power of Supplier
4.4.2. Power of Consumer
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Circadian Rhythm Sleep Disorder Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers & Distributors
6. Circadian Rhythm Sleep Disorder Market - By Types
6.1. Delayed Sleep Phase Disorder
6.2. Adavanced Sleep Phase Disorder
6.3. Non-24-hour Sleep-Wake Disorder
6.4. Irregular Sleep Wake Rhythm
6.3. Jet Lag Disorder
7. Circadian Rhythm Sleep Disorder Market - By Geography
7.1. North America
7.1.1. The U.S.
7.1.3. Rest of North America
7.2.1. The U.K.
7.2.6. Rest of Europe
7.3.5. Rest of APAC
7.4. Latin America
7.4.4. Rest of Latin America
7.5. Rest of the World
7.5.1. The Middle East
8. Circadian Rhythm Sleep Disorder Market Entropy
8.1. New Product Launches
8.2. M&As, Collaborations, Partnerships & JVs
9. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers)
9.1. Vanda Pharmaceuticals, Inc.
9.2. Takeda Pharmaceutical Company Limited
9.3. VU University Medical Center
9.4. U.S. Centers of Disease Control and Prevention
9.5. The Sunbox Company
9.6. American Academy of Sleep Medicine
9.7. National Organization for Rare Disorders
9.8. RaQualia Pharma
9.9. Reset Therapeutics, Inc.
"*Financials would be provided on a best efforts basis for private companies"
10.3. Research Methodology
10.5. Compilation of Expert Insights